What are the treatment options for Molluscum contagiosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Molluscum Contagiosum

Physical removal methods—including cryotherapy, curettage, or excision—are the recommended first-line treatments for molluscum contagiosum in both children and adults, with the goal of preventing transmission and reducing symptoms. 1, 2

First-Line Physical Treatments

Cryotherapy with Liquid Nitrogen

  • Cryotherapy is a recommended first-line therapy for molluscum contagiosum across all age groups 1, 2
  • Be aware that cryotherapy may cause postinflammatory hyperpigmentation or, less commonly, scarring 1

Surgical Removal Methods

  • Incision and curettage is an effective physical removal method 2
  • Simple excision or excision with cautery are equally effective first-line options 1, 2
  • These physical methods are particularly important when lesions are on or near the eyelids with associated conjunctivitis, as removal is necessary to resolve the conjunctivitis 1, 2

Topical Chemical Treatments

For Children

  • 10% potassium hydroxide solution has similar efficacy to cryotherapy in children and is a recommended first-line topical treatment 1
  • Cantharidin has shown effectiveness in observational studies, though randomized controlled trial evidence is limited 1
  • Do not use salicylic acid in children under 2 years due to risk of systemic toxicity 3

Imiquimod: Not Recommended

  • Imiquimod has not shown benefit compared to placebo in randomized controlled trials for molluscum contagiosum and is not recommended 1
  • In pediatric studies, imiquimod cream failed to demonstrate efficacy, with complete clearance rates of 24% in the imiquimod group versus 26-28% in the vehicle group 4
  • Despite being mentioned in some older literature as a novel option 5, 6, current high-quality evidence does not support its use 1, 4

Treatment Algorithm

Step 1: Confirm Diagnosis and Assess Disease Extent

  • Look for characteristic skin-colored, whitish, or pink papules with shiny surface and central umbilication 1, 2
  • Assess the number of lesions, location (especially proximity to eyes), and presence of complications such as conjunctivitis 1, 2
  • If lesions are multiple and large with minimal inflammation, consider screening for immunocompromised state 1, 2

Step 2: Identify All Lesions Including Nascent Ones

  • Carefully examine for nascent (early) lesions during initial treatment, as treating them simultaneously reduces risk of recurrence 1
  • Early lesions may appear as simple dome-shaped papules without central umbilication 1
  • Reducing viral load through comprehensive treatment allows the host immune response to eliminate residual virus 1, 2

Step 3: Select Treatment Based on Clinical Context

For Limited Disease in Immunocompetent Patients:

  • Proceed with physical removal methods (cryotherapy, curettage, or excision) 1, 2
  • In children, 10% potassium hydroxide solution is an alternative to cryotherapy 1

For Periocular Lesions with Conjunctivitis:

  • Physical removal is imperative to resolve conjunctivitis 1, 2
  • The conjunctivitis may require several weeks to resolve after lesion elimination 2

For Extensive or Recalcitrant Disease:

  • Consider referral to dermatology 1, 2
  • Screen for immunocompromised state 1, 2

For Immunocompromised Patients:

  • Lesions may be severe and recalcitrant, potentially requiring cidofovir, imiquimod, or interferon (though evidence for imiquimod is weak) 5
  • Referral to dermatology is recommended 1

Step 4: Follow-Up

  • Follow-up is not usually necessary unless conjunctivitis persists or new lesions develop 1, 2
  • Monitor for resolution of conjunctivitis if lesions were periocular 1

Watchful Waiting as an Alternative

  • Molluscum contagiosum typically resolves spontaneously within 6-12 months, though lesions can persist for 6 months to 5 years 1, 3
  • However, treatment is recommended to reduce risk of sexual transmission (in adults), prevent autoinoculation, and improve quality of life 7, 5, 8
  • The European guideline notes that waiting for spontaneous resolution is an option in immunocompetent patients 5

Critical Pitfalls to Avoid

  • Do not miss nascent lesions during initial treatment—this is a common cause of recurrence 1
  • Do not use imiquimod for molluscum contagiosum, as it lacks efficacy despite being mentioned in older literature 1, 4
  • Do not neglect periocular lesions, as they require active treatment to prevent ocular complications 1
  • Do not use salicylic acid in children under 2 years 3
  • Do not use ranitidine or other H2 blockers for molluscum contagiosum—there is no evidence supporting their efficacy 3

Special Populations

Pregnancy

  • Physical procedures such as cryotherapy are safe to use during pregnancy 5

Sexually Active Adults

  • Patients with genital molluscum contagiosum should be offered screening for other sexually transmitted infections 5, 8
  • Treatment is particularly recommended to reduce sexual transmission risk 7, 8

References

Guideline

Molluscum Contagiosum Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Molluscum Contagiosum in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ranitidine for Molluscum Contagiosum in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

2020 European guideline on the management of genital molluscum contagiosum.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2021

Research

Molluscum contagiosum: the importance of early diagnosis and treatment.

American journal of obstetrics and gynecology, 2003

Research

The challenges of a neglected STI: Molluscum contagiosum.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.